Voyager Therapeutics, Inc. Debt Securities, Available-for-sale, Unrealized Gain
Voyager Therapeutics, Inc. (VYGR) reported Debt Securities, Available-for-sale, Unrealized Gain of $7.90 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-03.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedGain · last filed 2023-08-03
- Voyager Therapeutics, Inc. debt securities, available-for-sale, unrealized gain for the quarter ending 2023-06-30 was $7.90M.
- Voyager Therapeutics, Inc. debt securities, available-for-sale, unrealized gain for the quarter ending 2023-03-31 was $0.00.
- Voyager Therapeutics, Inc. debt securities, available-for-sale, unrealized gain for the quarter ending 2022-12-31 was -$5.00M.
- Voyager Therapeutics, Inc. debt securities, available-for-sale, unrealized gain for fiscal 2016 was $2.00K.
| Period end | Debt Securities, Available-for-sale, Unrealized Gain 3 month | Debt Securities, Available-for-sale, Unrealized Gain 6 month | Debt Securities, Available-for-sale, Unrealized Gain 9 month | Debt Securities, Available-for-sale, Unrealized Gain 12 month |
|---|---|---|---|---|
| 2023-06-30 | $7.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $7.90M 10-Q · filed 2023-08-03 | $2.90M derived: sum of 3 quarters · filed 2023-08-03 | |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-09 | -$5.00M derived: sum of 2 quarters · filed 2023-08-03 | ||
| 2022-12-31 | -$5.00M derived: 10-Q 12 month − 10-Q 9 month · filed 2023-08-03 | $0.00 10-Q · filed 2023-08-03 | ||
| 2022-09-30 | $5.00M 10-Q · filed 2022-11-08 | |||
| 2021-12-31 | $0.00 10-Q · filed 2022-11-08 | |||
| 2016-12-31 | $2.00K 10-K · filed 2018-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |